首页> 美国卫生研究院文献>Annals of Translational Medicine >Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy

【2h】

Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy

机译：icotinib在EGFR突变状态未知对二线化疗无效的晚期非鳞状非小细胞肺癌患者中的临床疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundEvaluation of the clinical efficacy and safety of icotinib in advanced nonsquamous non-small cell lung cancer (NSCLC) patients with an unknown EGFR mutation who failed to respond to second-line chemotherapy.

机译：背景技术icotinib在EGFR突变未知，对二线化疗无效的晚期非鳞状非小细胞肺癌（NSCLC）患者中的临床疗效和安全性评估。

著录项

期刊名称 Annals of Translational Medicine
作者
Lu Xu; Xin-Hua Xu; Cheng Yuan; Jia-Yu Zhang; Xi Tang; Dian Chen; Xiao-Long Wang; Guang Zeng;
展开▼
作者单位

展开▼
年(卷),期 2018(6),20
年度 2018
页码 405
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-17 16:08:43

相似文献

外文文献
中文文献
专利

1. Icotinib alone or with bevacizumab as first-line therapy in Chinese patients with advanced nonsquamous non-small cell lung cancer and activating EGFR mutations: A retrospective study [J] . Zhansheng Jiang, Jing Zhang, Haiyan Sun, Thoracic cancer. . 2021,第17期

机译：单独的icotinib或贝伐单抗作为中国晚期非小细胞肺癌患者的一线治疗和激活EGFR突变：回顾性研究
2. P3.01-009 Clinical Efficacy of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 18 E709X Mutations [J] . C. Xu, W. Wang, W. Zhuang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P3.01-009 icotinib患者患有EGFR外显子18 E709x突变患者icotinib患者的临床疗效
3. Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations [J] . Minghui Zhang, Mingyang Liu, Yan Wang Journal of Thoracic Disease . 2016,第10期

机译：EGFR-TKI与患有EGFR突变的晚期非小细胞肺癌患者化疗组合的临床疗效
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
6. Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations [O] . Minghui Zhang, Mingyang Liu, Yan Wang 2016

机译：EGFR-TKIs联合化学疗法治疗携带EGFR突变的晚期非小细胞肺癌的临床疗效
7. Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial [O] . Jinghui Lin, Meifang Li, Shijie Chen, 2021

机译：第一代EGFR-TKI的疗效和安全性联合化疗治疗治疗 - 幼稚高级非小细胞肺癌患者，涉及敏感EGFR突变：单中心，开放标签，单臂，II期临床试验

Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅